Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Elie Traer

Has grant

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States

Recent Grants

Grant: Close

Clinical trial to target the leukemia microenvironment

Open Date: 2022-01-01

Close Date: 2024-06-30

Articles (17)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (27)

Fieke Hoff

National Institutes of Health

UNITED STATES

View details

Steven Knapper

Professor in Haematology

Cardiff University

UNITED KINGDOM

View details

James Blachly

Associate Professor of Internal Medicine

Ohio State University

UNITED STATES

View details

Wei Xie

Assistant professor

Oregon Health & Science University

UNITED STATES

View details

Kimmo Porkka

University of Helsinki

FINLAND

View details

Song Cao

Assistant Professor

Washington University in St. Louis

UNITED STATES

View details

Tara Lin

University of Kansas Medical Center

UNITED STATES

View details

Ghayas C. Issa

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

John C. Byrd

UPMC Hillman Cancer Center

UNITED STATES

View details

Shannon McWeeney

Professor and Vice Chair

Oregon Health & Science University

UNITED STATES

View details

Mika Kontro

Group Leader

University of Helsinki

FINLAND

View details

Sara Gosline

Assistant Professor

Oregon Health & Science University

UNITED STATES

View details

John F. DiPersio

Director, Center for Gene and Cellular Immunotherapy

Washington University in St. Louis

UNITED STATES

View details

Stephane De Botton

Institut Gustave Roussy

FRANCE

View details

David Dickens

Division Chief

Nemours Children's Clinic

UNITED STATES

View details

Jeffrey Tyner

Professor

Oregon Health & Science University

UNITED STATES

View details

Eduard Porta-Pardo

Junior Group Leader

Josep Carreras Leukaemia Research Institute

SPAIN

View details

Yazan F. Madanat

UNITED STATES

View details

Tao Liu

Sr. Staff Scientist

Pacific Northwest National Laboratory

UNITED STATES

View details

Wendy Stock

Professor of Medicine

University of Chicago

UNITED STATES

View details

Michael W. M Kühn

Professor of Medicine

University Medical Center of the Johannes Gutenberg University Mainz

GERMANY

View details

Jason McDermott

Team Lead

Oregon Health & Science University

UNITED STATES

View details

Maedeh Mohebnasab

Assistant Professor

UPMC Presbyterian

UNITED STATES

View details

Wojciech Kaspera

Medical University of Silesia

POLAND

View details

Simona Migliozzi

Assistant Professor

Translational Genomics Research Institute

UNITED STATES

View details

Joshua Zeidner

Associate Professor of Medicine

University of North Carolina, Lineberger Comprehensive Cancer Center

UNITED STATES

View details

Daniel Peters

Assistant Professor

Augusta University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Elie Traer

Research Interests

Explore related searches

Recent Grants

Articles (17)

Molecular characterization of newly diagnosed acute myeloid leukemia patients aged 60 years or older: a report from the Beat AML clinical trial

Genetic and Phenotypic Correlates of Clinical Outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN Study

Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1 -Mutated or KMT2A -Rearranged AML

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.

Multi-scale signaling and tumor evolution in high-grade gliomas.

Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

Beat-AML 2024 ELN-Refined Risk Stratification for Older Adults with Newly Diagnosed AML Given Lower-Intensity Therapy

Mapping the proteogenomic landscape enables prediction of drug response in acute myeloid leukemia

Thromboprophylaxis with intermediate dose enoxaparin during asparaginase containing induction for young adults with acute lymphoblastic leukemia.

Cytogenetically Cryptic Acute Promyelocytic Leukemia: A Diagnostic Challenge

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia

Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes

The FLT3<sup>N701K</sup> mutation causes clinical AML resistance to gilteritinib and triggers TKI sensitivity switch to quizartinib.

Mass Spectrometry-Based Proteogenomics: New Therapeutic Opportunities for Precision Medicine.

Building on Foundations: Venetoclax-Based Combinations in the Treatment of Acute Myeloid Leukemia.

Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates.

Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.

Collaborators (27)

Fieke Hoff

Steven Knapper

James Blachly

Wei Xie

Kimmo Porkka

Song Cao

Tara Lin

Ghayas C. Issa

John C. Byrd

Shannon McWeeney

Mika Kontro

Sara Gosline

John F. DiPersio

Stephane De Botton

David Dickens

Jeffrey Tyner

Eduard Porta-Pardo

Yazan F. Madanat

Tao Liu

Wendy Stock

Michael W. M Kühn

Jason McDermott

Maedeh Mohebnasab

Wojciech Kaspera

Simona Migliozzi

Joshua Zeidner

Daniel Peters

Make your next move.